Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio
CONCLUSION: Determination of the metabolizer phenotype according to CYP polymorphisms or the C/D ratio allows patients to be distinguished according to their exposure to Tac. Probably the combination of both classification criteria would be a good tool for managing Tac dosage for transplant patients.PMID:38614890 | DOI:10.1016/j.nefroe.2024.03.019
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Authors: Anna Vidal-Alabr ó Helena Colom Pere Fontova Gema Cerezo Edoardo Melilli Nuria Montero Ana Coloma Anna Manonelles Alex Fav à Josep M Cruzado Joan Torras Josep M Griny ó Nuria Lloberas Source Type: research
More News: Genetics | Kidney Transplant | Kidney Transplantation | Prograf | Statistics | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology